Karyopharm Therapeutics Inc (KPTI)

[TheFinalCD]

hit 8.16 ugh

[BottomBounce]

$BYND $TYME $NRE $KPTI $ACB Thinking about buying stock in Aurora Cannabis, Beyond Meat, Karyopharm Therapeutics, Northstar Realty, or Tyme Technologies? https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-aurora-cannabis-beyond-meat-karyopharm-therapeutics-northstar-realty-or-tyme-technologies-300880305.html

[stock1ace1]

8.40$ in flip #2

[ivarga]

Is it going back to $6?

[TheFinalCD]

nice buy hit 8.97 now 8.81

[stock1ace1]

Grabbed 8.60$

[TheFinalCD]

I missed buying 8.40-50

wasnt sure

[Pyramid2]

That trade eod, pure $,$$$!

GLTY!

[Pyramid2]

Sold the Gap up Pre, out $9.8. I took some $8.40's same channel, why CTU gap fill from halted market manipulation imo only, eod $8.80AH. I am thinking another gap up Monday pre.

Drug Sales start Wednesday 7/10/19.

[ClayTrader]

* * $KPTI Video Chart 07-05-2019 * *

Link to Video - click here to watch the technical chart video

[TheFinalCD]

8.50 off a dollar from needs to hold

KPTI

[TheFinalCD]

8.79 to 9.11 on the last 15m candle

[ilovestocks85]

Long at 8.90 today. Should see $15 soon

[DorseyE]

Karyopharm +3% as analysts boost targets on FDA approval

Jul. 5, 2019 11:39 AM ET|About: Karyopharm Therapeutics Inc. (KPTI)|By: Jason Aycock, SA News Editor
Karyopharm Therapeutics (NASDAQ:KPTI) is up 3% on its return to regular-session trading after it spiked 36% in Wednesday's shortened session amid an FDA approval for its selinexor, for treatment of penta-refractory multiple myeloma.

Shares today hit their highest point since mid-November, while analysts responded by raising price targets.

Baird boosted its target to $25 from $15 -- implying 173% upside -- and modeled $150M peak annual sales for the later-line approval. It says accelerated approval de-risks the market in second-line relapsed multiple myeloma, the more meaningful market.

Meanwhile RBC raised its target to $22 from $16, pointing to the lack of the most serious caution on the label: "The label includes no boxed warning, a win, and while it describes in detail the many AEs (adverse events) associated with Xpovio and the need for monitoring, it provides clear dose- adjustment schemes and guidelines for AE management.”

[Pyramid2]

we need to get through the sma20 on bb, than I will load more, she keeps touching the bottom and dropping 6x we have hit it from 9.27 7x and we are attacking again 8x on 2 min, she is weakened up and blast off soon

[TheFinalCD]

bottom Bollie test...

should hold


needs to hold

8.75 lod

KPTI

[TheFinalCD]

8.75's not buying more until this thing settles down

[TheFinalCD]

Filled Buy 1000 KPTI Limit 8.88 -- -- 11:45:50 07/05/19


Filled Buy 500 KPTI Limit 8.8899 -- -- 11:42:27 07/05/19


Filled Buy 163 KPTI Limit 9.00 -- -- 11:40:07 07/05/19


Filled Buy 10 KPTI Limit 9.00 -- -- 11:40:07 07/05/19


Filled Buy 55 KPTI Limit 9.00 -- -- 11:40:07 07/05/19


Filled Buy 102 KPTI Limit 9.00 -- -- 11:40:07 07/05/19


Filled Buy 170 KPTI Limit 9.00 -- -- 11:40:07 07/05/19



Filled Buy 500 KPTI Limit 9.1099 -- -- 11:16:17 07/05/19

[TheFinalCD]

9.10 whats your thoughts?

[TheFinalCD]

KPTI 9.18 whos BUYING?

[stock1ace1]

9.50$ needs to hold

[wesley_]

should see a nice leg up

[wesley_]

awesome 10+ pre market :)

[Roadtojourney]

Lol you might have just came in today i am still in but with news this should have blown away imo. Thats what i meant

[DorseyE]

$17 BY END OF DAY!

[stock1ace1]

Here comes the volume @9.55$

[stock1ace1]

10.50$ p/m

[Gpheart2016]

Last trade after hours yesterday was 9.38. I’m prepared to buy early in premarket tomorrow. May get some calls as well if I can jump in ahead of the market.

[Glider549]

Really?
LOL!

[stocktrademan]

KPTI buy 8.8962

https://www.karyopharm.com/

news
https://investors.karyopharm.com/news-releases/news-release-details/karyopharm-announces-fda-approval-xpoviotm-selinexor-treatment




normal chart









log chart









normal chart








log chart

[Pyramid2]

Nice Alert premarket Inner Circle,

Sadly, I did watch it trade flat early 2-3 times looking for a reason to enter moved on with another trade, came back to halt and scratched my head, saw FDA approval news, dropped back to $8.30 and I entered.

Gap up imo Friday pre.

GLTA

[DorseyE]

Anybody feel analyst “BUY” rating coming?

[pokerman000222]

What a move........Afternoon an the day before the 4th. Almost feel sorry for the shorts. Almost.

[wesley_]

$8.82 last 8's getting absorbed

[Roadtojourney]

Blood cancer drug got approve and this junk is going down, what a diluted pos imo??

[wesley_]

adding some 8's :) nice

[Roadtojourney]

And there is opens lower pos imo

[ClayTrader]

* * $KPTI Video Chart 07-03-2019 * *

Link to Video - click here to watch the technical chart video

[Disquisition]

FDA CONFIRMS APPROVAL 10 mins ago!!

https://www.streetinsider.com/dr/news.php?id=15675520

TRUMP! TRUMP! TRUMP!

[Roadtojourney]

The market is going to close soon why is it not unhalted yet??

[Roadtojourney]

That news is huge for kpti imo??

[DorseyE]

FDA OKs Karyopharm's selinexor for treatment-resistant multiple myeloma; shares up 36%

Jul. 3, 2019 10:51 AM ET|About: Karyopharm Therapeutic... (KPTI)|By: Douglas W. House, SA News Editor
Karyopharm Therapeutics (KPTI +35.5%) is up on more than a 6x surge in volume in response to the FDA nod for XPOVIO (selinexor) for the treatment of penta-refractory multiple myeloma.

The agency's action date was July 6.
https://seekingalpha.com/news/3475710-fda-oks-karyopharms-selinexor-treatment-resistant-multiple-myeloma-shares-36-percent

[wesley_]

I loaded some before the halt, hmm...

[Roadtojourney]

Thats funny, none of the ihubber got this on scanner??

[Roadtojourney]

Halted on pending news better be good.

[Roadtojourney]

Thought they only have 5% of float??

[wesley_]

$8.89 wow

[ClayTrader]

* * $KPTI Video Chart 07-02-2019 * *

Link to Video - click here to watch the technical chart video

[DorseyE]

Karyopharm Reports New and Updated Selinexor Combination Data from the Phase 1b/2 STOMP Study at the European Hematology Association 2019 Annual Meeting
https://seekingalpha.com/pr/17544827-karyopharm-reports-new-updated-selinexor-combination-data-phase-1b-2-stomp-study-european

[DorseyE]

I BOUGHT SHARES TODAy@5.40